BNP Paribas Financial Markets’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

BNP Paribas Financial Markets’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-150,000	Closed	-$15K	–	5632
2024 Q4	$15K	Hold	150,000	–	–	﹤0.01%	4773
2024 Q3	$10.6K	Hold	150,000	–	–	﹤0.01%	3796
2024 Q2	$14.8K	Hold	150,000	–	–	﹤0.01%	3681
2024 Q1	$21K	Buy	+150,000	New	+$17K	﹤0.01%	3642
2023 Q4	–	Sell	-150,000	Closed	-$59.2K	–	4116
2023 Q3	$59.2K	Hold	150,000	–	–	﹤0.01%	3435
2023 Q2	$31.4K	Hold	150,000	–	–	﹤0.01%	3551
2023 Q1	$21K	Hold	150,000	–	–	﹤0.01%	3509
2022 Q4	$12.7K	Buy	+150,000	New	+$12.6K	﹤0.01%	3591

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 18.84% 1-Year Est. Return

BNP Paribas Financial Markets's NKGNW Position: Q1 2025 in Review

BNP Paribas Financial Markets sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2025, closing a stake of 150,000 shares — an estimated $15K sold.

BNP Paribas Financial Markets first reported a position in NKGNW in Q4 2022 and held it in 8 quarters. The position peaked at $59.2K in Q3 2023. 3 funds tracked by Wall St. Rank hold NKGNW as of Q1 2025.

BNP Paribas Financial Markets reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2025 after selling out during the quarter.
BNP Paribas Financial Markets sold 150,000 NKGen Biotech, Inc. Warrants shares in Q1 2025, an estimated $15K.
BNP Paribas Financial Markets first reported a position in NKGen Biotech, Inc. Warrants in Q4 2022 and held it in 8 quarters.
BNP Paribas Financial Markets's NKGen Biotech, Inc. Warrants position peaked at $59.2K in Q3 2023.
3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2025, filed 14 May 2025.